Literature DB >> 4788030

Localization of the central cardiovascular action of clonidine.

P Bousquet, P G Guertzenstein.   

Abstract

1. The fall in arterial blood pressure with bradycardia that occurs on injection of clonidine into the cerebral ventricles and into the cisterna magna is attributed to an action on ;chemosensitive zones' situated at the ventral surface of the brain stem. This conclusion is based on the following results obtained in cats anaesthetized with pentobarbitone sodium.2. The fall in blood pressure no longer occurs on injection of clonidine (10 to 100 mug) into the cerebral ventricles when the passage of clonidine into the subarachnoid space is prevented by cannulation of the aqueduct. In this condition, the injections produce instead a rise in blood pressure.3. Applied bilaterally, by means of perspex rings, to the ventral surface of the brain stem, clonidine (10 mul of a 50 to 1,000 mug/ml solution placed in each ring) produces a fall in blood pressure with bradycardia, but only when the perspex rings cover the ;chemosensitive zones' from which changes in blood pressure and heart rate are obtained with various drugs.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4788030      PMCID: PMC1776600          DOI: 10.1111/j.1476-5381.1973.tb08532.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  [On the mechanism of action of a new antihypertensive substance with imidazoline structure].

Authors:  W Kobinger
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967

2.  Sites of central nervous action of clonidine on reflex autonomic function in the unanaesthetized rabbit.

Authors:  J Shaw; S N Hunyer; P I Korner
Journal:  Eur J Pharmacol       Date:  1971-06       Impact factor: 4.432

3.  Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). II. Central sympathetic structures.

Authors:  H Schmitt; J R Boissier; J F Giudicelli; J Fichelle
Journal:  Eur J Pharmacol       Date:  1968-03       Impact factor: 4.432

4.  Analysis of the cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (Catapres).

Authors:  J W Constantine; W K McShane
Journal:  Eur J Pharmacol       Date:  1968-09       Impact factor: 4.432

5.  Acute hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery.

Authors:  R W Sattler; P A van Zwieten
Journal:  Eur J Pharmacol       Date:  1967-10       Impact factor: 4.432

6.  Central noradrenergic neurones and the cardiovascular actions of clonidine in the rabbit.

Authors:  C T Dollery; J L Reid
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

7.  Blood pressure effects obtained by drugs applied to the ventral surface of the brain stem.

Authors:  P G Guertzenstein
Journal:  J Physiol       Date:  1973-03       Impact factor: 5.182

8.  Perfusion of cerebral ventricles: effects of drugs on outflow from the cisterna and the aqueduct.

Authors:  B K BHATTACHARYA; W FELDBERG
Journal:  Br J Pharmacol Chemother       Date:  1958-06

9.  Localization of the hypotenisve effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan).

Authors:  H Schmitt; H Schmitt
Journal:  Eur J Pharmacol       Date:  1969-04       Impact factor: 4.432

10.  A vasodepressor effect of pentobarbitone sodium.

Authors:  W Feldberg; P G Guertzenstein
Journal:  J Physiol       Date:  1972-07       Impact factor: 5.182

View more
  17 in total

1.  Comparison of the hyperglycaemic effect of adrenaline and morphine introduced into the liquor space.

Authors:  P K Dey; W Feldberg; S Wendlandt
Journal:  J Physiol       Date:  1975-03       Impact factor: 5.182

2.  Vasopressin release by nicotine: the site of action.

Authors:  W Feldberg; P G Guertzenstein; M Rocha e Silva
Journal:  Br J Pharmacol       Date:  1975-08       Impact factor: 8.739

3.  Pharmacology of guanfacine.

Authors:  G Scholtysik
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

4.  A central vasodepressor effect of Dyflos.

Authors:  H Edery; P G Guertzenstein
Journal:  Br J Pharmacol       Date:  1974-04       Impact factor: 8.739

5.  Fall in blood pressure produced from discrete regions of the ventral surface of the medulla by glycine and lesions.

Authors:  P G Guertzenstein; A Silver
Journal:  J Physiol       Date:  1974-10       Impact factor: 5.182

6.  Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit.

Authors:  J Feldman; E Tibiriça; G Bricca; M Dontenwill; A Belcourt; P Bousquet
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

7.  Pharmacokinetics and side-effects of clonidine.

Authors:  A Keränen; S Nykänen; J Taskinen
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

8.  Sympathoinhibitory effects of rilmenidine may be mediated by sites located below the brainstem.

Authors:  F Sannajust; C Barrès; E Koenig-Bérard; J Sassard
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

9.  Chronic haloperidol and adrenergic receptor sensitivity in the rat.

Authors:  A Perrington; R Einstein; D M Jackson; M J Christie
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.